Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Click here to view

Presentation

Genome Orthogonal Zinc Finger Proteins for the Development of Genomic Medicines

Download PDF